Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers
Open Access
- 11 February 2025
- journal article
- review article
- Published by MDPI AG in Biosensors
- Vol. 15 (2) , 102
Abstract
Monitoring and assessing the progression of symptoms in neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, are critical for improving patient outcomes. Traditional biomarkers, such as cerebrospinal fluid analysis and brain imaging, are widely used to investigate the underlying mechanisms of disease and enable early diagnosis. In contrast, digital biomarkers derived from phenotypic changes—such as EEG, eye movement, gait, and speech analysis—offer a noninvasive and accessible alternative. Leveraging portable and widely available devices, such as smartphones and wearable sensors, digital biomarkers are emerging as a promising tool for ND diagnosis and monitoring. This review highlights the comprehensive developments in digital biomarkers, emphasizing their unique advantages and integration potential alongside traditional biomarkers.Keywords
Funding Information
- National Research Foundation of Korea (2023R1A2C2007147, RS-2024-00416117, P0017805)
- Korean government (MSIT) (2023R1A2C2007147, RS-2024-00416117, P0017805)
- Korea Institute for Advancement of Technology (2023R1A2C2007147, RS-2024-00416117, P0017805)
This publication has 148 references indexed in Scilit:
- Changes of Dopamine Turnover in the Progression of Parkinson's Disease as Measured by Positron Emission Tomography: Their Relation to Disease-Compensatory MechanismsJournal of Cerebral Blood Flow & Metabolism, 2004
- The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendationsMovement Disorders, 2003
- Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observationsMovement Disorders, 2003
- Alzheimer's Disease and Parkinson's DiseaseNew England Journal of Medicine, 2003
- Lifetime symptoms of depression in Alzheimer's diseaseEuropean Psychiatry, 2003
- Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer diseaseNature Medicine, 2003
- The effects of APOE genotype on age at onset and progression of neurodegenerative diseasesNeurology, 2001
- A multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonismNeurology, 2000
- Tau Protein and the Neurofibrillary Pathology of Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 1996
- Eye tracking dysfunction in Alzheimer‐type dementiaNeurology, 1984